Cardiovascular Research Serraflazyme Serratiopeptidase Enzyme Supplement 100 Tablets

Expiration dates range from 12 to 24 months

Cardiovascular Research Serraflazyme Serratiopeptidase Enzyme Supplement 100 Tablets

SKU: C-SERRA
UPC: 696859034909

Description
Cardiovascular Research Serraflazyme 120 Tablets is a serratiopeptidase enzyme tablet product formulated for research use only positioning within a general nutritional and wellness context. Cardiovascular Research Serraflazyme 120 Tablets is designed for individuals who prefer a clean label enzyme based formulation as part of a structured daily supplement routine. Cardiovascular Research Serraflazyme 120 Tablets is manufactured using a coated tablet system intended for controlled release as part of a standard dietary regimen.

This product contains serratiopeptidase in a precisely measured amount per tablet and is produced with a focus on ingredient consistency and formulation stability. Cardiovascular Research Serraflazyme 120 Tablets uses an intestinal coating system designed to support tablet integrity during passage through the stomach before dissolution. Cardiovascular Research Serraflazyme 120 Tablets is made without unnecessary additives, artificial preservatives, or common allergens.

The formulation is intended for general dietary and informational use and is not positioned for medical or therapeutic claims. Cardiovascular Research Serraflazyme 120 Tablets is suitable for adults seeking a simplified enzyme product within a daily wellness routine focused on clean ingredient profiles and consistent dosing structure.

Health Benefits

1. Cardiovascular Research Serraflazyme 120 Tablets supports general enzyme based nutritional balance in daily routines
2. Cardiovascular Research Serraflazyme 120 Tablets supports routine dietary wellness through standardized enzyme intake
3. Cardiovascular Research Serraflazyme 120 Tablets supports clean label supplement preferences with minimal ingredients
4. Cardiovascular Research Serraflazyme 120 Tablets supports daily nutritional structure as part of general wellness plans
5. Cardiovascular Research Serraflazyme 120 Tablets supports enzyme based dietary variety within a balanced lifestyle approach

Product Highlights

1. Cardiovascular Research Serraflazyme 120 Tablets contains serratiopeptidase enzyme in tablet form
2. Cardiovascular Research Serraflazyme 120 Tablets uses intestinal coated delivery system for controlled release
3. Cardiovascular Research Serraflazyme 120 Tablets is free from gluten soy dairy and artificial preservatives
4. Cardiovascular Research Serraflazyme 120 Tablets is designed for daily nutritional use in adults
5. Cardiovascular Research Serraflazyme 120 Tablets follows clean label manufacturing standards for ingredient simplicity

Ingredients
Cardiovascular Research Serraflazyme 120 Tablets contains serratiopeptidase enzyme as the active ingredient. Cardiovascular Research Serraflazyme 120 Tablets also includes microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide, and an intestinal tablet coating system. Cardiovascular Research Serraflazyme 120 Tablets is formulated without gluten, soy, dairy, or artificial preservatives to maintain a simplified ingredient profile.

Dosage
Cardiovascular Research Serraflazyme 120 Tablets is intended for adult use in a general dietary context. Take 1 tablet daily with water or as directed by a qualified professional. Cardiovascular Research Serraflazyme 120 Tablets may be taken with meals as part of a routine nutritional schedule.